Hay C - Search Results

1

An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease.

Cumming A, Grundy P, Keeney S, Lester W, Enayat S, Guilliatt A, Bowen D, Pasi J, Keeling D, Hill F, Bolton-Maggs PH, Hay C, Collins P; UK Haemophilia Centre Doctors' Organisation. Cumming A, et al. Among authors: hay c. Thromb Haemost. 2006 Nov;96(5):630-41. Thromb Haemost. 2006. PMID: 17080221

2

A whole blood, multiplex PCR detection method for factor V Leiden and the prothrombin G20210A variant.

Keeney S, Salden A, Hay C, Cumming A. Keeney S, et al. Among authors: hay c. Thromb Haemost. 1999 Mar;81(3):464-5. Thromb Haemost. 1999. PMID: 10102480 No abstract available.

3

Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.

Keeney S, Cumming A, Hay C. Keeney S, et al. Among authors: hay c. Thromb Haemost. 1999 Nov;82(5):1446-50. Thromb Haemost. 1999. PMID: 10595636

4

Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

Pasi KJ, Collins PW, Keeling DM, Brown SA, Cumming AM, Dolan GC, Hay CR, Hill FG, Laffan M, Peake IR. Pasi KJ, et al. Among authors: hay cr. Haemophilia. 2004 May;10(3):218-31. doi: 10.1111/j.1365-2516.2004.00886.x. Haemophilia. 2004. PMID: 15086319

5

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99.

Darby SC, Keeling DM, Spooner RJ, Wan Kan S, Giangrande PL, Collins PW, Hill FG, Hay CR; UK Haemophilia Centre Doctors' Organisation. Darby SC, et al. Among authors: hay cr. J Thromb Haemost. 2004 Jul;2(7):1047-54. doi: 10.1046/j.1538-7836.2004.00710.x. J Thromb Haemost. 2004. PMID: 15219185 Free article.

6

Thrombosis and recombinant factor VIIa.

Hay CR. Hay CR. J Thromb Haemost. 2004 Oct;2(10):1698-9. doi: 10.1111/j.1538-7836.2004.00943.x. J Thromb Haemost. 2004. PMID: 15456477 Free article. No abstract available.

7

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. Hay CR, et al. Br J Haematol. 2006 Jun;133(6):591-605. doi: 10.1111/j.1365-2141.2006.06087.x. Br J Haematol. 2006. PMID: 16704433 Free article. Review.

8

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CR; UK Haemophilia Centre Doctors' Organisation. Collins PW, et al. Blood. 2007 Mar 1;109(5):1870-7. doi: 10.1182/blood-2006-06-029850. Epub 2006 Oct 17. Blood. 2007. PMID: 17047148 Free article.

9

The importance of tissue factor source in the management of Factor VII deficiency.

Bolton-Maggs PH, Hay CR, Shanks D, Mitchell MJ, McVey JH. Bolton-Maggs PH, et al. Thromb Haemost. 2007 Jan;97(1):151-2. Thromb Haemost. 2007. PMID: 17200783 No abstract available.

10

A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3.

Sutherland MS, Cumming AM, Bowman M, Bolton-Maggs PH, Bowen DJ, Collins PW, Hay CR, Will AM, Keeney S. Sutherland MS, et al. Blood. 2009 Jul 30;114(5):1091-8. doi: 10.1182/blood-2008-08-173278. Epub 2009 Apr 16. Blood. 2009. PMID: 19372260 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters